Publications by authors named "Sean Ferree"

Claim this Profile
A
Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors.
Daniel R Zollinger, Elizabeth Rivers, Alexander Fine, Yanmei Huang, Joseph Son, Sean Ferree

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Drivers of Onco DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
Richard Buus, Ivana Sestak, Ralf Kronenwett, Sean Ferree, Catherine A Schnabel

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Gene Expression-Based Biomarkers on the nCounter Platform for Immuno-Oncology Applications.
Sarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, Lynell Skewis, Brett Wallden, Sean Ferree

Methods Mol Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
Anne-Vibeke Lænkholm, Maj-Britt Jensen, Jens Ole Eriksen, Anne Roslind, Wesley Buckingham, Sean Ferree

Clin Breast Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients.
Maj-Britt Jensen, Anne-Vibeke Lænkholm, Eva Balslev, Wesley Buckingham, Sean Ferree

NPJ Breast Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Patrick Danaher, Sarah Warren, Su Fey Ong, Nathan Elliott, Alessandra Cesano, Sean Ferree

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Patrick Danaher, Sarah Warren, SuFey Ong, Nathan Elliott, Alessandra Cesano, Sean Ferree

J Immunother Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.
Maj-Britt Jensen, Anne-Vibeke Lænkholm, Torsten O Nielsen, Jens Ole Eriksen, Pernille Wehn, Sean Ferree

Breast Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ivana Sestak, Richard Buus, Jack Cuzick, Peter Dubsky, Ralf Kronenwett, Sean Ferree

JAMA Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.
Anne-Vibeke Lænkholm, Maj-Britt Jensen, Jens Ole Eriksen, Birgitte Bruun Rasmussen, Ann S Knoop, Sean Ferree

J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes.
Anne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, Wesley Buckingham, Sean Ferree

Acta Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
Edith A Perez, Karla V Ballman, Afshin Mashadi-Hossein, Kathleen S Tenner, Jennifer M Kachergus, Sean Ferree

J Natl Cancer Inst· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
Ivana Sestak, Mitch Dowsett, Sean Ferree, Frederick L Baehner, Jack Cuzick

Breast Cancer Res Treat· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay.
Aleix Prat, Patricia Galván, Begoña Jimenez, Wesley Buckingham, H Arthur Jeiranian, Sean Ferree

Clin Cancer Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Brett Wallden, James Storhoff, Torsten Nielsen, Naeem Dowidar, Carl Schaper, Sean Ferree

BMC Med Genomics· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.
Miguel Martín, Milagros González-Rivera, Serafín Morales, Juan de la Haba-Rodriguez, Lucía González-Cortijo, Sean Ferree

Curr Med Res Opin· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.
Ivana Sestak, Jack Cuzick, Mitch Dowsett, Elena Lopez-Knowles, Martin Filipits, Sean Ferree

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Martin Filipits, Torsten O Nielsen, Margaretha Rudas, Richard Greil, Herbert Stöger, Sean Ferree

Clin Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
Torsten Nielsen, Brett Wallden, Carl Schaper, Sean Ferree, Shuzhen Liu

BMC Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
Ivana Sestak, Mitch Dowsett, Lila Zabaglo, Elena Lopez-Knowles, Sean Ferree

J Natl Cancer Inst· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
Mitch Dowsett, Ivana Sestak, Elena Lopez-Knowles, Kalvinder Sidhu, Anita K Dunbier, Sean Ferree

J Clin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct multiplexed measurement of gene expression with color-coded probe pairs.
Gary K Geiss, Roger E Bumgarner, Brian Birditt, Timothy Dahl, Naeem Dowidar, Sean Ferree

Nat Biotechnol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hydrodynamics of DNA electrophoretic stretch and relaxation in a polymer solution.
Sean Ferree, Harvey W Blanch

Biophys J· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrokinetic stretching of tethered DNA.
Sean Ferree, Harvey W Blanch

Biophys J· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis